This document discusses benign ovarian tumors, including functional ovarian cysts and benign neoplastic ovarian tumors. It describes the main types of functional cysts such as follicular, lutein and hemorrhagic cysts. It also outlines the main types of benign neoplastic ovarian tumors, including epithelial tumors, sex cord-stromal tumors, germ cell tumors and mixed tumors. The diagnosis, management and treatment options for different types of benign ovarian tumors are provided.
Benign ovarian masses include functional cysts and tumors; most are asymptomatic.Most functional cysts and benign tumors are asymptomatic. Sometimes they cause menstrual abnormalities. Hemorrhagic corpus luteum cysts may cause pain or signs of peritonitis, particularly when they rupture. Occasionally, severe abdominal pain results from adnexal torsion of a cyst or mass, usually > 4 cm. Treatment varies depending on the patient's reproductive status.
Presentation about the the second most common type of ovarian tumors which have a very unique property of being similar to the testicular germ cell tumors.
Benign ovarian masses include functional cysts and tumors; most are asymptomatic.Most functional cysts and benign tumors are asymptomatic. Sometimes they cause menstrual abnormalities. Hemorrhagic corpus luteum cysts may cause pain or signs of peritonitis, particularly when they rupture. Occasionally, severe abdominal pain results from adnexal torsion of a cyst or mass, usually > 4 cm. Treatment varies depending on the patient's reproductive status.
Presentation about the the second most common type of ovarian tumors which have a very unique property of being similar to the testicular germ cell tumors.
Cervical and broad ligament fibroids are rare; with incidence of only 2% and 1% respectively.
Cervical fibroid often present with pressure symptoms and often pose surgical difficulties due to its proximity to bladder and rectum.
Broad ligament fibroid though rare , but have the propensity of growing into large adnexal masses and may mimic ovarian malignancy.
India is the highest TB burden country accounting for more than one-fourth of the global incidence .Genital TB is found in 5-10% of women with infertility problems, with low rates in Australia (1%) and high rates of up to 19% in India (ICMR,2011)
4 cases of pelvic mass are discussed .Adnexal mass invilves masses arisinf from ovary,fallopian tube,uterus,bowel and some miscellenious masses.USG is used to detect its size and the origin.Histopathological findings are diagnostic.
Cervical and broad ligament fibroids are rare; with incidence of only 2% and 1% respectively.
Cervical fibroid often present with pressure symptoms and often pose surgical difficulties due to its proximity to bladder and rectum.
Broad ligament fibroid though rare , but have the propensity of growing into large adnexal masses and may mimic ovarian malignancy.
India is the highest TB burden country accounting for more than one-fourth of the global incidence .Genital TB is found in 5-10% of women with infertility problems, with low rates in Australia (1%) and high rates of up to 19% in India (ICMR,2011)
4 cases of pelvic mass are discussed .Adnexal mass invilves masses arisinf from ovary,fallopian tube,uterus,bowel and some miscellenious masses.USG is used to detect its size and the origin.Histopathological findings are diagnostic.
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng trứng thể túi noãn hoàng tại bệnh viện K
Phí tải 20.000đ liên hệ quangthuboss@gmail.com
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ MIỆNG Ở MỘT SỐ BỆNH VIỆN TẠI HÀ NỘI
Phí tải 20.000đ liên hệ quangthuboss@gmail.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
3. Functional Ovarian Cysts
- Childhood 70% functional.
- To be classified as functional cyst most be at least
3 cm diameter.
- General signs and symptoms : pelvic pain , dull
sensation , heaviness in the pelvis.
5. Functional Ovarian Cysts
A / TYPES:
1 - Follicular cyst : when the ovarian follicle fails to
rupture.
2 - Lutein cyst : when the corpus luteum becomes
cystic and fails to regress after 14 days , Solid +
small, pain/peritoneal irratation, delayed
menses ?.
6. Functional Ovarian Cysts
3- Hemorrhagic cysts : symptoms + rupture.
( proliferative phase ? ).
4- Theca-lutein cysts : associated with high hCG ,
hydatidform mole, choriocarcinoma , ovulation
induction .
# bilateral , large ( > 30 cm ) , regress after
gonadotrophin levels fall ( massive ascites ,
systimic fluid imbalance ) ??
7. Functional Ovarian Cysts
5- Luteoma of pregnancy : hyperplastic reaction of
ovarian theca cells ( hCG ).
# brown to reddish nodules , cystic or solid ,
associated with multifetal pregnancies ,
hydraminos.
# Cause maternal virilization and ambiguous
genitalia in female fetus.
# Regreess postpartum ??
8. Functional Ovarian Cysts
Gross appearance of a luteoma of pregnancy. Note the multiple
brown nodules. (From Voet RL: Color Atlas of Obstetric and
Gynecologic Pathology. St. Louis, Mosby, 1997.)
9. Functional Ovarian Cysts
Ovary with multiple cysts lining the capsule consistent with
polycystic ovary syndrome. (Courtesy of Dr. Sathima Natarajan,
Ronald Reagan-UCLA Medical Center.)
10. Functional Ovarian Cysts
B / CLINICAL FEATURES :
# ASYMPTOMATIC , unilocular , up to 15 cm ,
regress during the subsequent menstrual cycle.
# Torsion ?
# Rupture ? ( acute abdominal pain and tenderness + hemperitoneum ) !!!!!
# Amenorrhea , AUB , severe pelvic pain ( what to
exclude first ?) ( EP , ruptured cyst , torsion and
pelvic abscess ) immediate pregnancy test and
laparoscopy.
11. Functional Ovarian Cysts
C / DIAGNOSIS:
# Hx + Ex ( bimanual ) cm ?? ( 5 – 8 cm ) + mobile.
** confirmation of regression by the next cycle.
# Not associated with ascites.
# More than 8 cm and tender ( rare )
# Hemorrhagic cysts may feel solid.
12. Functional Ovarian Cysts
C / DIAGNOSIS:
# Imaging :
US ** confirms cystic nature only ( cystic VS neoplastic ) ??
# Laboratory:
CA 125
# Surgical procedure :
*** Laparoscopic cystectomy VS aspiration ??
If suspicious >>>>> RMI .
16. Functional Ovarian Cysts
C / DIAGNOSIS:
RMI ( Risk for Malignancy Index )
Calculation of RMI for an ovarian mass
Criteria
Scoring System
A- Menopausal Status
Premenopausal
1
Postmenopausal
3
B- Ultrasonic Features
Multiloculated
1 feature = 1
Solid areas
bilaterality
≥ 2 features = 3
ascites
C- Serum CA – 125 Titer
Absolute value
17. Functional Ovarian Cysts
D / MANAGMENT :
# Reproductive age +asymptomatic or mild( US + CA 125 + RMI )
1- if low RMI and possible functional cyst:
>>> re-evaluate after next menses . ( low dose COP ? )
2- if high RMI , solid , painful or fixed :
>>> surgical exploration or referral to gynecologic
oncologist .
18. Functional Ovarian Cysts
D / MANAGMENT :
# if perimenopausal no delays even if
asymptomatic . ( US + CA 125 + RMI )
19. Benign Neoplastic Ovarian Tumors
A / TYPES:
1- Epithelial ovarian neoplasm. ( most common
CATEGORY )
2- Sex cord – Stromal ovarian neoplasm.
3- Germ cell ovarian neoplasm. ( dermoid cyst most
common TYPE )
4- Mixed ovarian neoplasm.( more than one type of
cell )
20. Benign Neoplastic Ovarian Tumors
1- Epithelial ovarian neoplasm:
# Derived from the mesothelium on the
peretionium and the ovary:
A- Mucinous.
B- Endometriod.
C- Serous.
D- Brenner tumor.
22. Benign Neoplastic Ovarian Tumors
1- Epithelial ovarian neoplasm:
C- Serous : resembles fallopian tube.
# 70% benign , multilocular, psammoma bodies ,
bilateral 10% ( most common ).
D- Brenner tumor : resembles transiotional cells of
the bladder.
# Small Smooth Solid and Fibrotic , associated
with mucinous epithelial elements? ( 33 % ).
23. Functional Ovarian Cysts
Gross appearance of a mucinous (A) and serous (B) cystadenoma of the
ovary. The mucinous type is generally multiloculated and can be quite
large. (A, From Voet RL: Color Atlas of Obstetric and Gynecologic
Pathology. St. Louis, Mosby, 1997, Fig. 6.31; B, from Voet RL: Color Atlas
of Obstetric and Gynecologic Pathology. St. Louis, Mosby, 1997, Fig.
6.20.)
•
24. Functional Ovarian Cysts
Gross appearance of a cut-open Brenner tumor. (Courtesy of Dr.
Sathima Natarajan, Ronald Reagan-UCLA Medical Center.)
25. Benign Neoplastic Ovarian Tumors
2- Sex cord – Stromal ovarian neoplasm:
# Derived from the sex cords and specialized
stroma of the developing gonads :
A- Functioning ovarian tumors :
1- Granulosa – Theca cell tumors.
2- Sertoli – Leydig cell tumors.
3- Gynandroblastomas .
***Ultimate differentiation
B- Ovarian Fibromas .
28. Benign Neoplastic Ovarian Tumors
2- Sex cord – Stromal ovarian neoplasm:
B- Ovarian Fibromas:
# mature fibroblasts of the ovarian stroma.
# Smooth , Solid , Encapsulated , not hormonally
active.
# ascites/ meigs syndrome ?
# fibrothecoma ? .
# Pure thecoma – ednocrinologic effects ?
29. Functional Ovarian Cysts
Gross appearance of an ovarian fi broma. (Courtesy of Dr. Sathima
Natarajan, Ronald Reagan-UCLA Medical Center.)
30. Benign Neoplastic Ovarian Tumors
3- Germ cell ovarian neoplasm:
# Dermoid cyst ( Benign cystic teratoma ) :
- Ectodermal + mesodermal ± endodermal tussue.
-Slow growing , less than 10 cm.
-10-15% are bilateral .
-Well differentiated tissue indicates to more
benign teratoma.
-
31. Functional Ovarian Cysts
Gross appearance of a cut-open dermoid cyst. Note the presence
of hair-bearing skin. (From Voet RL: Color Atlas of Obstetric and
Gynecologic Pathology. St. Louis, Mosby, 1997.)
32. Benign Neoplastic Ovarian Tumors
4- Mixed ovarian neoplasm:
# Most common of this category is the
cystadenofibroma which is mostly epithelial
component.
# Ganoadoblastoma : resembles dysgerminoma ,
granulosa and sertoli.
- calcific concretions , almost all patients have
dysgenetic gonads + Y chromosome , half
develop dysgerminomas ( malignancy ).
33. Benign Neoplastic Ovarian Tumors
C / DIAGNOSIS:
# Hx + Ex ( bimanual ).
# Mostly asymptomatic ( except functioning ovarian
tumors ) untill torsion or rupture :
- sever abdominal pain , peritoneal irritation ,
abdominal regidity and paralytic ilus.
- Cysts can rupture during bimanual Ex or intercourse.
( contents of the cyst maybe troublesome !! ).
34. Benign Neoplastic Ovarian Tumors
C / DIAGNOSIS:
- Bimanual Ex:
If the mass is separate from the uterus ; adnexal
mass is probable .
- Abdominal Ex : if too large can be palpable ,
cysts are dull to percussion ( anteriorly ) and
tympany of the bowel on the flanks.
35. Benign Neoplastic Ovarian Tumors
C / DIAGNOSIS:
# Imaging
US ( Transvaginal and pelvic ): ** tooth like calcification ??
# Lab :
Serum CA 125 ** RMI
# Surgical procedures :
- Laparoscopy ** distinguish B/W uterine myoma ,
hydrosalpinx and ovarian tumor but not B/W functional cyst
, benign ovarian neoplasm and encapsulated malignant
ovarian tumor.
- Laparatomy ** preferable for definitive evaluation and
resection
36. Benign Neoplastic Ovarian Tumors
D / MANAGMENT :
# No persistant ovarian neoplasm sould be
assumed to be benign untill proved so by
surgical exploration and pathalogic
examination**.
# Laparatomy indicated ** drain ascites , take
biopsy and send to lab.
37. Benign Neoplastic Ovarian Tumors
D / MANAGMENT :
1- Benign epithelial :
# unilateral salpingo-oopheroctomy+ inspect
contralateral ovary ?? Bilateral lesion and coexistant
appendiceal mucocele and do appendictomy.
# If young and nullipara:
- ovarian cystectomy.
# If older women :
- total abdominal hysterectomy and bilateral salpingooopherectomy.